Clinical Trials Logo

Abnormal Vaginal Flora clinical trials

View clinical trials related to Abnormal Vaginal Flora.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01287728 Completed - Clinical trials for Abnormal Vaginal Flora

The Value of Bacterial Loads by Real Time PCR in Predicting Recurrence of Abnormal Vaginal Flora After Oral Metronidazole Therapy

Start date: January 2011
Phase: Phase 3
Study type: Interventional

Abnormal vaginal flora is currently diagnosed among women (20-40%). It is associated with symptoms (bad smell, vaginal discharge) and adverse out-comes in pregnant and not pregnant women. The high recurrence rate raises the long-term effectiveness of therapy. The hypothesis is the persistence of bacteria associated with vaginal flora imbalance as Atopobium vaginae and Gardnerella vaginalis. At the present time there is a lack of an accurate marker for the risk of recurrence.